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Abstract
To study the roles of microRNA-223 (miR-223) in regulation of cell growth, we established a miR-223 over-expression model
in HeLa cells infected with miR-223 by Lentivirus pLL3.7 system. We observed in this model that miR-223 significantly
suppressed the proliferation, growth rate, colony formation of HeLa cells in vitro, and in vivo tumorigenicity or tumor
formation in nude mice. To investigate the mechanisms involved, we scanned and examined the potential and putative
target molecules of miR-223 by informatics, quantitative PCR and Western blot, and found that insulin-like growth factor-1
receptor (IGF-1R) was the functional target of miR-223 inhibition of cell proliferation. Targeting IGF-1R by miR-223 was not
only seen in HeLa cells, but also in leukemia and hepatoma cells. The downstream pathway, Akt/mTOR/p70S6K, to which
the signal was mediated by IGF-1R, was inhibited as well. The relative luciferase activity of the reporter containing wild-type
39UTR(39untranslated region) of IGF-1R was significantly suppressed, but the mutant not. Silence of IGF-1R expression by
vector-based short hairpin RNA resulted in the similar inhibition with miR-223. Contrarily, rescued IGF-1R expression in the
cells that over-expressed miR-223, reversed the inhibition caused by miR-223 via introducing IGF-1R cDNA that didn’t
contain the 39UTR. Meanwhile, we also noted that miR-223 targeted Rasa1, but the downstream molecules mediated by
Rasa1 was neither targeted nor regulated. Therefore we believed that IGF-1R was the functional target for miR-223
suppression of cell proliferation and its downstream PI3K/Akt/mTOR/p70S6K pathway suppressed by miR-223 was by
targeting IGF-1R.
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Introduction
MicroRNAs (miRNAs) are short (20-23 nucleotides), endoge-
nous, single-stranded RNA molecules that regulate gene expres-
sion [1,2]. MicroRNA-223 (miR-223) was identified bioinforma-
tically and subsequently characterized in the hematopoietic
system, where it is mainly expressed in the myeloid, granulocytic,
and monocytic compartments [3,4], but not in B and T
lymphocytes. The highest levels of expression is observed in bone
marrow CD34
- fraction, that is representative of lineage-
committed precursors and mature hematopoietic cells [5]. The
miR-223 locus is located on the X chromosome and is transcribed
independently of any known genes [5,6]. MiR-223 acts as ‘‘a fine-
tuner’’ of granulocytic differentiation and maturation [7] and
promotes granulocytic differentiation in acute promyelocytic
leukemia (APL) cells treated with retinoic acid (RA) which can
induce up-regulation of C/EBPa (CCAAT-enhancer-binding
proteins a). C/EBP acan further compete with NF1A and
promote miR-223 expression [5,6]. The expression of miR-223
was then reported to promote granulocytic differentiation [8].
The abnormal signal pathway activation is important in tumor
and leukemia cell development. This includes PI3K/Akt,
mTOR(mammalian target of rapamycin), ERK/MAPK,
STAT3/5, NF-kB, protein kinase C [9,10] and Wnt/b-catenin
[11] as well as insulin-like growth factor-1 receptor (IGF-1R) signal
pathway. IGF-1R system is comprised of two ligands (IGF-1,2);
three cellular membrane-spanning receptors IGF-1 receptor (IGF-
1R), insulin receptor, and IGF-2R; and six high-affinity IGF-
binding proteins IGFBP1-6, playing the pivotal role in normal
growth and development of the cells [12]. After IGF-1 binding to
IGF-1R, the signal pathway PI3K/Akt and mTOR are activated
to regulate cell proliferation, and are also activated in tumor cells
such as acute myeloid leukemia [11]. Once activated, the signaling
through Akt can be propagated to a diverse array of substrates
including mTOR, a key regulator of protein translation. This
pathway is an attractive therapeutic target in cancer treatment
because it serves as a convergence point for many growth stimuli,
and through its downstream substrates, it controls cellular
processes that contribute to the initiation and maintenance of
cancer [13].
However, the detailed mechanisms of miR-223 in differentia-
tion or tumor progression still remain unclear. The functions of
miR-223 in previous reports were not clear or somewhat
contradicted in both hematopoietic and non-hematopoietic
systems. Although miR-223 was thought to promote differentia-
tion, some documents reported that miR-223 negatively regulates
granulocyte differentiation in miR-223
-/Y transgenic mice [14]. It
was also reported that miR-223 was significantly up-regulated in
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hepatocellular carcinoma cells (HCC) miR-223 was repressed as
compared with normal liver tissue by microarrays [17] and
STMN1 was the potential target which serves as an oncogene
implicating that miR-223 may serve as a tumor suppressor[18]. In
this study, we investigated the roles of miR-223 in cell growth and
sought for the mechanism by which the inhibition of cell growth
by miR-223 is mediated.
Results
Over-expression of miR-223 in HeLa cells
Lentivirus vector is an efficient, stable gene delivery tool in
mammalian cells to induce stable gain- and loss-of-function
phenotypes for individual miRNAs [19] or shRNAs [20].
Therefore Lentivirus vector pLL3.7 was used in this study to
establish miR-223 over-expression. Packaging of virus was
performed by co-transfection of three plasmids and the efficiency
was about 70% (Fig. 1-A) according to GFP (green fluorescent
protein) signal that was carried by pLL3.7 vector or pLL3.7-miR-
223. Infection was performed with the lentivirus at a ratio of 1:1
(v/v) with 8 mg/ml polybrene, twice. After infection of HeLa cells
with either EV(Empty Virus Vector) (Fig. 1-B, left) or pLL3.7-
miR-223 (right), the infected cells were screened and sorted by a
FACS machine based on the expression of GFP which indicated
the presence of the plasmids pLL3.7-miR-223 or the EV (Fig. 1-
C). The expression of miR-223 in miR-223 group was up-
regulated 7.19 folds after sorting as compared with EV group,
which was confirmed by both semi-quantitative RT-PCR (reverse
transcription polymerase chain reaction) and quantitative PCR
(Fig. 1-D, E) besides the fluorescent measurement. The sorted
miR-223-infected HeLa cells were then used as the stable miR-223
overexpression model. We referred to the infected cells by either
miR-223 or EV as miR-223 or EV groups respectively, in the
following experiments.
MiR-223 suppression of HeLa cell proliferation
To observe the effect of miR-223 on the HeLa cells, cell growth
rate in stable miR-223-infected HeLa cells was evaluated by CCK-
8 assay. In the 5 day’s growth rate observation, the proliferation
rate of miR-223 group was reduced 2.42 folds as compared with
EV group (p,0.05) (Fig. 2-A). To further evaluate the proliferation
ability, we then performed the colony formation assay and found
that the capacity of colony formation was significantly inhibited in
MiR-223 group. The number of colonies, which were defined as
more than 50 cells which derived from a single cell, in miR-223
group was greatly repressed to 43.72% of the control and the
difference of the colony number between the two groups reached
significance (p,0.01) (Fig. 2-B,C). To further confirm the above
findings, an in vivo model was carried out by subcutaneous
injection of 5610
6 EV or miR-223-infected cells into the mouse
skin under the front right or left legs respectively. The tumor mass
became palpable 8 to 11 days after inoculation in all (8/8) mice in
EV group (three representative mice in Fig. 2-D), but no tumor
was observed in one of the eight mice in MiR-223 group. Five
weeks after inoculation, all mice were sacrificed and the tumor
mass was weighted. The average tumor weight of miR-223 group
was significantly less than control (p,0.05, Fig. 2-E). Tumor size in
two groups were measured every three days after tumor were
palpable and the results indicated that tumor volumes in miR-223
group only achieved 62.3% of the control (p,0.05) (Fig. 2-F). All
the tumor masses were examined and confirmed histologically by
HE (hematoxylin and eosin) staining (Fig. 2-G). These results
suggested that miR-223 suppressed the proliferation of HeLa cells
both in vitro and in vivo.
IGF-1R was targeted by miR-223
To further investigate the mechanism of miR-223 inhibition of
tumorigenicity and proliferation of HeLa cells, we searched for
potential targets by using the prediction algorithm of Targetscan
5.1, 9 molecules including POLE3, POLR3G, FBXW7, IGF-1R,
p70S6K, Rasa1, Fox O1, Fox O3 and Cdc27 were selected.
Screen results by quantitative PCR suggested that the expression
of POLE3, POLR3G, FBXW7, Mef 2C, LMO2, NF1A and
STMN1 did not reduce significantly in miR-223 group although
the examination was at mRNA levels. However, we found that
IGF-1R mRNA was reduced significantly in miR-223 group as
compared with EV group (p,0.05) (Fig. 3-A). Using 2 different
pairs of primers achieved the same results. Precursor and mature
IGF-1R proteins were also significantly reduced to 41.4% and
32.7% in miR-223 group as compared with EV group (p,0.01)
(Fig. 3-B,C). The phosphorylated IGF-1R was reduced accor-
dantly (Fig. 3-B,D). To confirm that IGF-1R was targeted by miR-
223, we cloned the 39UTR of IGF-1R into the site directly
downstream of the luciferase reporter gene in psi-CHECK
TM-2 and
constructed the three nucleotide mutation within the region that
miR-223 seed sequence potentially bound with (Fig. 3-E). We
found that the relative luciferase activity of the reporter that
contained wild-type 39UTR of IGF-1R was significantly sup-
pressed in miR-223 group as compared with EV group (p,0.01)
(Fig. 3-F). However, the relative luciferase activity of the mutant
IGF-1R 39UTR reporter construct with 3 nucleotide mutation
within the putative seed sequence (226-228bp in IGF-1R 39UTR)
(Fig. 3-E) was almost at the same level as the control psi-
CHECK
TM-2 group and failed to respond to miR-223 (Fig. 3-F).
MiR-223 suppression of IGF-1R expression could be reversed by
adding exogenous miR-223 inhibitor at the final concentration of
50 nM (p,0.01) (Fig. 3-F). By re-expression of IGF-1R, the
growth rate of miR-223 group that was transfected with IGF-1R
rose after 48 hours and reached to 1.98 folds as much as the group
of miR-223 at the time point of 72 hours post transfection (Fig. 3-
G). Transfection with IGF-1R cDNA(complementary DNA) could
totally overcome the suppression caused by miR-223 (Fig. 3-B)
since the construct contained no 39UTR. In the tumor tissues at
xenograft nude mice, the expression of IGF-1R was also
suppressed in miR-223 group as compared with EV group
(Fig. 3-H).
MiR-223 inhibition of Akt/mTOR/p70S6K signal pathway
As miR-223 suppressed IGF-1R expression, the next question
that needed to uncover was whether the IGF-1R-mediated
downstream signal pathway was also impacted by miR-223. To
this end, the expressions of Akt, an essential protein kinase in
PI3K/Akt pathway downstream of IGF-1R and of its active form
(p-Akt) were examined. We observed that the p-Akt was reduced
to about 32.4% of the EV group, but the total Akt was unaffected
(Fig. 4-A,B). The molecules downstream and inhibited by Akt/p-
Akt including p27 were up-regulated (Fig. 4-A). The up-regulation
of p27 at mRNA level was further supported by quantitative PCR
(Fig. 4-C). In contrast, cyclin D1 and Bcl-2, an anti-apoptotic
regulator, that are normally promoted by p-Akt, were down
regulated at both protein and mRNA levels (Fig. 4-A,C). To
further investigate the pathway alteration at miR-223 group, we
detected p-70S6K, a key protein kinase in mTOR signal pathway,
and its active form (p-p70S6K) and found that p-p70S6K was
greatly reduced in miR-223 group to 58% of the EV group (Fig. 4-
A,B), but total p70S6K was unaffected. Since p70S6K is a
MiR-223 Targets IGF-1R
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required for the cancer cell-induced tumor growth and angiogen-
esis [21] and for vascular endothelial growth factor (VEGF)
expression, we also examined HIF-1a expression in this model to
observe the effect of p70S6K inhibition. Interestingly, HIF-1a was
strikingly reduced to 54.4% in miR-223 group as compared with
control EV group (Fig. 4-A,C), which was consistent with a
previous report [21]. Moreover, re-expression of IGF-1R which
did not contain the 39UTR totally reversed the inhibition of Akt/
mTOR/p70S6K signal pathway profile (Fig. 4-A).
Knockdown of IGF-1R mimicked miR-223 inhibition
Our results thus far demonstrate that miR-223 suppressed IGF-
1R in both mRNA and protein levels, and subsequently
suppressed the downstream Akt/mTOR/p70S6K signal pathway.
To further demonstrate that IGF-1R targeting by miR-223 is
sufficient to effect the reduced cell proliferation phenotype, we
performed a loss-of-function experiment by transfection of IGF-
1R-sh carried by plasmid pSilencer 4.1CMV-puro into HeLa cells.
The expression of IGF-1R was successfully knocked down (Fig. 5-
A) by IGF-1R-sh through transient transfection, and this led to a
similar suppression of the cell growth as miR-223. Knockdown of
IGF-1R not only decreased cell viability (Fig. 5-B), but also
inhibited the PI3K/Akt/mTOR/p70S6K signal pathway (Fig. 5-
C) mentioned above, which was quite similar to the inhibition by
miR-223. These results strongly indicated that miR-223 sup-
pressed of Akt/mTOR/p70S6K pathway is by targeting IGF-1R.
The regulation of miR-223 relied on the pathway
triggered by the target
Since one miRNA may target a dozen of targets, in this model
we further investigated the response of several additional mRNA
targets that might be regulated. However, mRNAs predicted by
Targetscan 5.1 and reported previously, such as LMO2, STMN1,
Mef 2C, FBXW7 and NF1A (Fig. 6), did not significantly decrease
in our system although they were examined only at mRNA level.
Rasa1 was predicted by Targetscan 5.1 as a target of miR-223 and
indeed observed to be targeted by miR-223 in current study at
both mRNA and protein levels (Fig. 7-A,B). The luciferase
reporter assay did show that the 39UTR of Rasa1 mRNA was
targeted by miR-223 directly (Fig. 7-C). Rasa1 exerted a tumor
suppressor function by removing GTP from RAS-GTP. Its down-
regulation should activate the Rasa1/RAF/MEK/ERK signal
pathway. However, ERK1/2 was down-regulated not only at the
total protein level, but also at phosphorylation level in miR-223
group as compared with EV group (Fig. 7-B) which indicated that
ERK pathway was inhibited even though Rasa1 was targeted.
Therefore Rasa1 could not be the functional target of miR-223 in
this system because it failed to regulate ERK pathway after miR-
223 targeting. Suppression of IGF-1R-mediated pathway might
lead to inhibition of ERK signaling, which may circumvent any
regulatory role for Rasa1 in this system. Whether a miRNA can
give dominant and full play to the regulation of cells may thus
depend on the relative importance of the target that involved in
the signal pathway.
Figure 1. Lentivirus-mediated miR-223 over-expression in HeLa cells. (A) Lentivirus vector pLL3.7-miR-223 was packaged in HEK-293T cells
which was less 20 generations. The packaging efficiency was evaluated by GFP fluorescent signal. Original magnification 10 6(B) HeLa cells were
infected with the Lentivirus which was packaged and prepared from HEK-293T cells. The GFP fluorescent signal could be stably observed 72 hours
after infection. EV group stood for vector control at the left and pLL3.7-miR-223 infection group was at the right. Original magnification 206(C) The
infected HeLa cells were sorted by FACS. The fluorescence-positive cells were collected in either EV control (left) or miR-223 (right) group. Original
magnification 106(D,E) Mir-223 was over-expressed in HeLa cells and confirmed by both stem-loop RT-PCR (D) and quantitative PCR (E). NV: no virus
control, EV: empty virus vector control, Input: positive mature miR-223.
doi:10.1371/journal.pone.0027008.g001
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PLoS ONE | www.plosone.org 3 November 2011 | Volume 6 | Issue 11 | e27008Figure 2. Overexpression of miR-223 suppressed HeLa cell growth. (A) Growth curves of miR-223 and EV-infected HeLa cells were conducted
by CCK-8 assay. The OD value at 450 nm represented the viable cell numbers. All experiments were carried 3 times independently. **p,0.01 (B)
Colony formation was assayed in miR-223 and EV-infected HeLa cells, and colonies consisting more than 50 cells were counted. The experiment was
repeated 3 times independently. (C) Bar graphs show the average number of colonies and comparison between EV and miR-223 groups. **p,0.01 (D)
Tumor sizes of 3 representative nude mice. MiR-223(right) and EV group(left) cells were injected subcutaneously in 8 female nude mice. The tumor
volume was measured every 3 days with calipers after tumor appeared. (E) Bar graphs show the average tumor weight (gram). * p,0.05 (F) Tumor
size observation in nude mice after the inoculation. The average size of the tumors was measured on every three days and shown in the curves. The
error bars show SD (standard deviation). (G) Histological examination of tumor tissues formed in nude mice. HE (hematoxylin and eosin) staining was
at the top panel. The middle panel shows the examination under a phase contrast microscope. The bottom panel shows the GFP signal carried by the
pLL3.7 vector under a fluorescent microscope and indicated the formation of tumor caused by either miR-223 or EV-infected HeLa cells.
doi:10.1371/journal.pone.0027008.g002
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cells
To investigate IGF-1R as the general target of miRNA-223,
miR-223 targeting IGF-1R was further studied in several other
tumor cell lines. In NB4 cells, promyelocytic leukemia cells, which
were treated with retinoic acid, the expression level of miR-223
increased abruptly (Fig. 8-A, left panel, p,0.05). While, IGF-1
mRNA expression was suppressed (Fig. 8-A, right panel) and the
cell growth inhibited significantly with mature morphology change
(Fig. 8-B). Transfection with miR-223 in NB4 cells also led to
significant inhibition of IGF-1R mRNA and protein expression
(p,0.05) (Fig. 8-C,D) and the cell growth (Fig. 8-E). In SMMC-
7721, BEL-7404, or Huh-7 hepatoma cells infected with miR-223
constructs, all the cell growth rates slowed down (Fig. 8-E) and the
expression level of IGF-1R was significantly inhibited (Fig. 8-F,G).
This result suggested that miR-223 targeted IGF-1R not only in
HeLa cells, but also in leukemia and hepatoma cells.
Discussion
In this study, we established a miR-223 over-expression model
and observed miR-223 suppression of cell growth, colony
formation in vitro, and the tumorigenesis in vivo. These results
suggest that miR-223 functioned as a negative regulator or tumor
suppressor for the cell growth, which is consistent with the role of
miR-223 in HCC [18]. In order to find out the mechanisms and
target mRNAs that were responsible for the suppressive function
Figure 4. MiR-223 suppressed IGF-1R-mediated Akt/mTOR/p70S6K signal pathway. (A): The Akt/mTOR/p70S6K pathway downstream of
IGF-1R were suppressed in miR-223 group. By Western blot, the two major protein kinases Akt and p70S6K revealed significant suppression and were
less phosphorylated. P27 protein was up-regulated. Bcl-2, a protein that was promoted by Akt was down-regulated. HIF-1a, the direct target of
p70S6K, was significantly inhibited. The inhibition of Akt/mTOR/p70S6K was reversed by re-expression of IGF-1R (IGF-1R rescued) in miR-223 group.
(B): Quantification of p-Akt, p-p70S6K in Fig. 4-A by densitometry to analyze the integral density of each band. *p,0.05 (C): Quantitative PCR analysis
of the mRNA expression levels of HIF-1a, p27, and Cyclin D1. *p,0.05.
doi:10.1371/journal.pone.0027008.g004
Figure 3. IGF-1R was directly targeted by miR-223. (A) Quantitative PCR results of IGF-1R. Two pairs of primers (IGF-1R-1 and IGF-1R-2)
designed at different positions of IGF-1R produced similar results showing suppression caused by miR-223. (B) IGF-1R protein level was suppressed by
miR-223. Both precursor and mature IGF-1R (2 bands) were suppressed after miR-223 overexpression. The phosphorylation level was subsequently
down regulated in agreement with the total protein level of IGF-1R. The suppression was abolished by transfection of the cells with IGF-1R cDNA
without 39UTR. (C) (D) The protein bands were scanned to measure the integral density in B experiments and normalized to those of GAPDH. The
relative expression was then compared. Experiments were carried out 3 independent times. *p,0.05, **p,0.01 (E) The top panel showed the
structure and cloning site of psi-CHECK
TM-2 vector. Wild type and three nucleotides mutated within IGF-1R 39UTR were cloned into the reporter based
on the predicted binding site in the 39UTR of IGF-1R with miR-223 seed sequence. The right panel showed that sequences of either wild type (upper)
or mutant (down) were confirmed by sequencing. (F) Dual Luciferase experiment of IGF-1R 39UTR was conducted. The expression of the reporter
containing IGF-1R 39UTR was suppressed by miR-223, but not in the mutated construct. Inhibition of miR-223 abolished the suppression of miR-223
on IGF-1R 39UTR at a final concentration of 50 nM. **p,0.01 (G) Growth curve was measured by CCK-8 assay and the results indicated that the
suppression of miR-223 group could be overcome by re-expression of IGF-1R. The group transfected with pcDNA 3.1-His/Myc served as the control.
**p,0.01 (H): Immunohistochemical staining of IGF-1R in the sections. IGF-1R was labeled in red carried by secondary antibody and the signal was
stronger in EV group. In miR-223 group, the signal of IGF-1R staining was significantly weaker than that in EV group. In blank group, PBS replaced the
first antibody in either EV or miR-223 group. Original magnification 10 6.
doi:10.1371/journal.pone.0027008.g003
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PLoS ONE | www.plosone.org 6 November 2011 | Volume 6 | Issue 11 | e27008Figure 5. Interference of IGF-1R mimicked the suppression of growth and Akt/mTOR/p70S6K signal pathway by miR-223. (A):
Inhibition of IGF-1R was seen after transfection with pSilencer 4.1-IGF-1R-shRNA to HeLa cells. Both phosphorylation and total protein levels were
reduced and the results were similar to the inhibition miR-223. (B): Growth rate in HeLa cells transfected with IGF-1R-sh was measured by CCK-8 kit.
**p,0.01 (C): The Akt/mTOR/p70S6K signal pathway was suppressed by transfection of IGF-1R-sh1, which was similar with the suppression caused by
miR-223.
doi:10.1371/journal.pone.0027008.g005
Figure 6. Quantitative PCR analysis of the mRNA expression levels of FBXW7 (A), LMO2, Mef 2C and STMN1 (B), NF1A (C) in EV and
miR-223 groups.
doi:10.1371/journal.pone.0027008.g006
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including FBXW7, LMO2, STMN1, Mef 2C, NF1A and found
that all their mRNA levels changed slightly. However, we
observed that IGF-1R was strongly targeted by miR-223. There
are several lines of evidence in our study to support this. First,
IGF-1R 3 `UTR reporter experiment showed a significant decrease
in luciferase activity after miR-223 over-expression. Second,
mutation of three nucleotides of IGF-1R 39UTR within miR-
223 seed sequence binding site abolished the response to miR-223.
When we inhibited miR-223 with synthetic sponge inhibitor, miR-
223 lost its inhibitory function and the Renilla luciferase activities
of IGF-1R 39UTR reporter returned to the level similar to control
group. Third, both mRNA and protein of IGF-1R were down
regulated in miR-223 group as compared with EV group, but
transfection with IGF-1R cDNA without 39UTR sequence
overcome the inhibition by miR-223 and rescued the expression
of IGF-1R. These results strongly indicated that the wild type
39UTR of IGF-1R interacted with miR-223 and was suppressed at
both transcription and translation stages. Mature IGF-1R
appeared at 2 bands which might be due to different modifica-
tions, but reduced together in miR-223 group.
IGF-1R signal pathway was involved in the development and
tumorigenesis at many aspects. IGF signaling abnormality appears
to directly interfere with the normal cell growth regulation and
proapoptotic responses triggered by activation of p53, the tumor
suppressor, upon the treatment with anti-cancer agents[22]. In this
study, we investigated and found that PI3K/Akt/mTOR/
p70S6K signal pathway was suppressed by miR-223 (Fig. 4-A).
The signaling pathway of mTOR is important in miR-223
regulation of cell growth, which is consistent with the previous
bioinformatics prediction [16]. We also noted that re-expression of
IGF-1R in miR-223 group could abolish the inhibition effect of
miR-223 and reversed the inhibition of IGF-1R-mediated
downstream Akt/mTOR/p70S6K signal pathway. Further,
Figure 7. The expression profile of Rasa1/RAF/MEK/ERK pathway. (A): Quantitative PCR analysis of the mRNA levels of Rasa1. (B): Western
blot analysis of the protein levels of Rasa1, p-ERK1/2 and ERK1/2. GAPDH served as a loading control. (C): Dual luciferase report assay showed that
Rasa1 was targeted by miR-223. The expression of Rasa1 was suppressed by miR-223, but the mutant couldn’t. The inhibitor of miR-223 abolished the
suppression of miR-223 on Rasa1 at a final concentration of 50 nM. Three independent experiments were carried out to achieve similar results.
** p,0.01.
doi:10.1371/journal.pone.0027008.g007
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PLoS ONE | www.plosone.org 9 November 2011 | Volume 6 | Issue 11 | e27008knockdown of IGF-1R by shRNA could induce similar inhibitory
effects with miR-223 on IGF-1R and Akt/mTOR/p70S6K signal
pathway.
In the present study, miR-223 suppressed IGF-1R and its
signalingand acted as a tumor suppressor. On the other hand, miR-
223 is significantly up-regulated in bladder cancers [15], recurrent
ovarian cancer [16] and increases cyclin E protein and activity
levels, and elevates genomic instability [23]. Thus miR-223 might
serve as a doubled-edge sword by targeting opposite functional
targets, since one miRNA can target a dozen mRNAs which impact
many molecules that are involved in different signal pathways. The
dominant influence of a miRNA on the regulated function of cells
may depend on the relative importance of the targets that are
involved in different signal pathways. In this model, miR-223
targeted IGF-1R and its downstream signal pathway, which exerted
a major function in tumor cell growth regulation. IGF-1R was the
major mRNA among the miR-223 targets in our study. LMO2,
STMN1, Mef2C, FBXW7 and NF1A did not significantly decrease
in our system. Indeed several other molecules including Rasa1 were
also observed to be targeted by miR-223 in current study at both
mRNA and protein levels. The luciferase reporter assay did show
that the 39UTR of Rasa1 gene was targeted by miR-223 directly.
Rasa1 exerts a tumor suppressor function by removing GTP from
RAS-GTP. Its down-regulation should activate the Rasa1/RAF/
MEK/ERK signal pathway. However, ERK1/2 was down-
regulated not only at total protein level, but also at phosphorylation
level in miR-223 group as compared with the group, which
indicated that ERK pathway was inhibited although Rasa1
was targeted. Rasa1 encodes p120-RasGAP — a RasGTPase
which reverts active GTP-bound into inactive GDP-bound form
[24].ThereforeRasa1couldnotbethefunctionaltargetofmiR-223
because it failed to regulate ERK pathway after miR-223 targeting.
However, IGF-1R could be the functional target of miR-223, which
was responsible for the inhibition of cell growth. Suppression of
IGF-1R-mediated pathway might lead to inhibition of ERK
signaling, which made Rasa1 lose its regulatory role in signaling.
Furthermore, IGF-1R was also down regulated in NB4 (promyelo-
cytic leukemia) cells infected with miR-223. When NB4 cells were
induced with retinoic acid to differentiation, miR-223 was greatly
up-regulated, but IGF-1R down regulated, which suggested that
IGF-1R acted as the target. In hepatoma cells (SMMC-7721, BEL-
7404, or Huh-7) IGF-1R also served as the common target when
miR-223 inhibited the cell growth.
In summary (Fig. 9), we established a miR-223 overexpression
model by using lentivirus delivery system and observed that miR-
223 suppressed the proliferation of tumor cells both in vivo and in
vitro. It was through IGF-1R and its downstream signal pathway
that miR-223 suppressed the cell growth.
Materials and Methods
Plasmid construction
To construct the lentivirus vector pLL 3.7-miR-223 which
expressed miR-223, a fragment encoding the pre-miR-223
Figure 9. Summary of miR-223 inhibiting tumor growth by targeting IGF-1R and suppressing the downstream Akt/mTOR/p70S6K
signal pathway. The arrow indicated the major results of up-regulation and down-regulation.
doi:10.1371/journal.pone.0027008.g009
Figure 8. miR-223 regulated IGF-1R in other tumor cells. (A) NB4 cells were treated with 1 mmol/L retinoic acid for 48h and the expression
level of miR-223 was determined by quantitative PCR (left panel). In the treated cells the expression level of IGF-1R was measured by quantitative PCR
(right panel). (B) Wright-Giemsa staining of the cells. Much more post-mitotic cells (metamyelocytes, segmented neutrophils) were seen in the treated
group. Original magnification 1006(C) NB4 cells were infected with miR-223 construct. High expression of miR-223 (left panel) was confirmed by
quantitative PCR. The expression level of IGF-1R was also examined and down regulated in miR-223 group. (D) Western blot analysis of IGF-1R
expression in NB4 cells infected with miR-223 construct. (E) Growth curve of BEL-7704, SMMC-7721, Huh-7, and NB4 cells infected with miR-223
construct. The measurement of cell growth rate was performed by using CCK-8 kit. **P,0.01. N=6. (F) IGF-1R expression was measured by
quantitative PCR and was down-regulated in both SMMC-7721 and BEL-7404 cells infected with miR-223 construct. (G) After infection of miR-223 into
Huh-7 cells, IGF-1R mRNA was also down regulated. All figures are representative of the study and additionally at least three independent
experiments yielded similar results. *p,0.05.
doi:10.1371/journal.pone.0027008.g008
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(chrX:65238602-65238931, from UCSC web site) was amplified
with the primers 59CCGGTTAACCTGGCAGTCCATTCGT-
CA39and 59CCGCTCGAGCCTCTAGGGTCACATCTCC39
by PCR from NB4 cell genomic DNA and then cloned into the
Hpa I/Xho l sites of pLL 3.7 vector.
Psi-CHECK
TM-2-IGF-39UTR: The 39 UTR fragment (39untrans-
lated region) of IGF-1R (Genbank ACCESSION: NM_000875)
containing the binding site (from 1 to 3636 bp in the 39UTR of IGF-
1R) was amplified by PCR using the primers 59CCCCCTCGAG-
GATCCTGAATCTGTGCAAAC and 39AAAAGCGGCCGC-
CTTCCCAGCGAAATCATC 39 and cloned into Xho I/Not I sites
of psi-CHECK
TM-2. This vector allowed simultaneous expression of
renilla and firefly luciferases. The IGF-1R 39UTR was cloned
downstream of the renilla luciferase gene allowing the expression of
a renilla transcript with the 39UTR from IGF-1R. Renilla luciferase
activity was then used to assess the effect of the 39UTR on transcript
stability and translation efficiency. The second reporter, firefly
luciferase serves as control.
Psi-CHECK
TM-2-IGF-39UTR-mut: Three nucleotides of
39UTR of IGF-1R within the perfect binding site with miR-223
seed sequence, was mutated at the position of 226-228, from
AACTGAC to AAgacAC by PCR mutagenesis using the following
primers 59 AAACCCTTAAGACACATGGGCCT 39 and 59
AAGGCCCATGTGTCTTAAGGGTT 39. Successful mutations
were confirmed by DNA sequencing.
PSilencer 4.1 CMV puro-IGF-1R-sh: To silence IGF-1R
expression, we constructed a vector-based IGF-1R-shRNA to
interfere the expression of IGF-1R. The oligonucleotides we used
were 59GATCCGGCCAGAAATGGAGAATAATTCAAGAG-
ATTATTCTCCATTTCTGGCCTCA39 and 59AGCTTGAG-
GCCAGAAATGGAGAATAATCTCTTGAATTATTCTCCA-
TTTCTGGCCG39 and were cloned into the Bam H1 and Hind
III sites of pSilencer-4.1-CMV puro vector. The construction of
IGF-1R-shRNA was confirmed by DNA sequencing.
Cell culture, Lentivirus packaging and infection
HeLa, and HEK-293T cells from ATCC, SMMC-7721, BEL-
7404, or Huh-7 cells from Biochemistry and Cell biology Institute
of Shanghai, Chinese Academy of Science, were cultured in
DMEM supplemented with 10% fetal calf serum (Gibco BRL,
Carlsbad, CA, USA). The Lentivirus-mediated miR-223 packag-
ing system contained three plasmids pLL3.7 or pLL3.7-miR-223,
D8.9 and Vsvg at the ratio of 4:3:2 in quantity. Total of 12 mgo f
the plasmids were co-transfected with 30 ml Lipofectamine
TM2000
(Invitrogen, Carlsbad, CA, USA) into HEK-293T cells in a 100
mm diameter culture dish. When the transfected cells were at 80-
90% confluence, the supernatant was collected 48 hours post-
infection and filtered by a filter with 0.45 micrometer pore size and
used as the virus source.
HeLa cells was infected with either pLL3.7(EV) or pLL3.7-miR-
223 in the presence of 8 mg/ml polybrene (Sigma-Aldrich, St.
Louis, MO, USA) for 12 hours, and the medium was refreshed.
72 hours post the infection, the efficiency of infection was
measured under a fluorescent microscope and the cells were
sorted by a FACS (fluorescent activated cell sorter, Becton
Dickinson, Mountain View, CA, USA) based on the expression
of GFP carried by pLL 3.7 plasmid. The sorted cells were taken as
the over-expression model for the following experiments.
Luciferase reporter assay
Luciferase reporter assay was performed in HEK-293T cells.
Forty eight hours post transfection, the cells were washed with PBS
twice and lyzed in 100 ml Passive Lysis Buffer (Promega, Madison,
WI, USA) and the luciferase activities were measured from 20 ml
lysate using the Dual Luciferase reporter assay kit (Promega,
Madison, WI, USA) on a illuminometer (Lumat LB 9507,
Berthold, Germany). All the data were obtained by averaging
the results from six independent repeats. The mutated psi-
CHECK
TM-2-IGF-1R 39UTR was also transfected under the same
condition, and the miR-223 inhibitor and its control were used at
the final concentration of 50 nM to measure the inhibitory effect
of miR-223 on the 39UTR of IGF-1R.
Colony formation assay
The method was according to our previous report[25]. Briefly,
cells were digested with trypsin and suspended into a single cell
status. 6000 cells from each group were cultured in the 60 mm
diameter culture dish with 10% FBS for 14 days. The colonies
were fixed and stained with 0.5% crystal violet for 15 min, and
then washed 3 times. The colonies consisting of more than 50 cells
were defined as one colony. The number of colonies in 10 random
view fields was counted under a microscope and the average
representing the 95% confident region was achieved. The
experiment was carried out 3 independent times.
Tumor inoculation assay in nude mice
Female BALB/c athymic nude mice at the age of 5 to 6 weeks
were from SINO-BRITISH SIPPR/BK LAB ANIMAL LTD,
CO. (Shanghai, China). All the animals used in this study were
approved by Shanghai Municipal Government with the permit
number of 00800161308. All the procedures involving animals
were according to the NIH Guide for the Care and Use of
Laboratory Animals and local institutional ethical guidelines for
animal experiment. This experiment was approved by Experi-
mental Animal Ethics Committee, Fudan University Shanghai
Medical College with the permit number of 20110307-092. 5610
6
miR-223 or EV-infected HeLa single cell suspensions in 150 ml
sterile PBS were injected subcutaneously to the skin under the
front legs of the mouse. Tumor growth was examined every 3 days
for 5 weeks and its volume (V) was monitored by measuring the
length (L) and width (W) of the tumor with calipers and calculated
with the formula V= 1/2(L6W
2).
RNA extraction and quantitative PCR
Total RNA was extracted from cells using Trizol reagent
(Invitrogen, Carlsbad, CA, USA) and reverse transcription reaction
was performed with RT Kit according to the manufacturer’s protocol
(Invitrogen, Carlsbad, CA, USA) based on our previous report[26].
Normalization of miR-223 was performed by using RNU6 primers in
miR-223 and b-actin in other protein coding genes, respectively.
50 nM miRNA specific stem-loop RT primers [27] were used for
reverse transcription reaction as the following. 59GTCGTATC-
CAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACT-
GGGGT 39 for miR-223 and 59AAAATATGGAACGCT 39 for the
loading control RNU6, and quantitative PCR to detect mature miR-
223 with specific primers was performed with 26SYBR Green Master
Mix (DBI Bioscience, Shanghai, China) according to the protocol as
our previous report[28]. The primers used in this experiment are as the
following: 59GTGCAGGGTCCGAGGT39 and 59CGGGCTG-
TCAGTTTGTCA39 for miR-223; 59CTCGCTTCGGCAGCACA
39 and 59AACGCTTCACGAATTTGCGT 39 for RNU6;
…59GAGCTACGAGCTGCCTGACG39 and 59CCTAGAAG-
CATTTGCGGTGG39 for loading control b-actin; 59TGAACA-
GAATGGAATGGAGC39and 59ACTTTCATCCATTGATTG-
CC39 for HIF-1a;5 9TTATGTTCTTTTTCCCCCTT39 and 59
TGCCCACAAATTATCTTCTATC39 for p70S6K; 59 GGA-
CAGGTCAGAGGGTTTC and 59CTCGTAACTCTTCTCTG-
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59CATCTCCCAATGCTGCTTAG39 for IGF-1R-2; 59 GCAACC-
GACGATTCTTCTAC39 and 59TCGAGCTGTTTACGTTTG-
AC39 for p27; 59TACTACCGCCTCACACGC39 and 59CTCCT-
CCTCCTCCTCTTCCT 39 for cyclin D1; 59GGCTTCAGAAA-
TACTTCCACC39 and 59 GCAGGACAGATGAGTCGAAG 39for
Rasa1; 59 TGGGACTTGAGTGGTTTGTAG39 and 59CAGTT-
TAGGTTGCTACAGGCT39 for Fox O1; 59CTGAGGAAGGG-
GAAGTGG39 and 59 GTAAACGGTATCACTGTCCACT39 for
Fox O3; 59 ACATTAGTGGGACATACAGGTG39 and 59CATA-
CAACGCACAGTGGAAGT39for FBXW7. PCR was performed by
iQ5
TM quantitative PCR detection system (Bio-Rad, Alfred Nobel
Drive, Hercules, CA, USA) and results were analyzed with IQ5
software. All reactions were run in triplicate and all experiments were
carried 3 independent times.
Western blot
Fifty micrograms of total proteins were loaded onto 10%
sodium dodecyl sulfate–polyacrylamide gel electrophoresis and
transferred onto polyvinylidene difluoride(PVDF) membranes
(Millipore, Billerico, Massochusatts, USA). After blocking with
1% bovine serum albumin, the blots were incubated with
antibodies against IGF-1R, HIF-1a, p70S6K, p- p70S6K, Akt,
p-Akt (Bioworld, Atlanta, Georgia 30305, USA), p27, cyclin
D1(Neomarkers, Fremont, CA, USA), ERK1/2, p-ERK1/2, or
Bcl-2(Cell Signaling Technology Inc, 3 Trask Lane, Danvers, MA
01923, USA) glyceraldehyde- 3-phosphate dehydrogenase
(GAPDH) (Chemicon International, Temecula, CA, USA). After
incubation with horseradish peroxidase-conjugated secondary
antibody, protein bands were visualized using enhanced chemilu-
minescence detection kit (Millipore, Billerico, Massochusatts,
USA). The intensity of the bands was analyzed using Image-Pro
Plus software.
Immunohistochemistry
Immunohistochemistry was performed according to our previ-
ous documents [29,30]. Tumor specimens were taken from the
sacrificed nude mice, dehydrated with 15%/30% gradient sucrose,
and fixed with opti-mum cutting temperature compound (OCT)
(SAKURA, Tokyo, Japan). The sections were permeabilized with
0.5% Triton-X100 at room temperature for 10 min, washed three
times with PBS, blocked with 5% donkey serum, and incubated
with IGF-1R antibody in 5% donkey serum at 4uC for 24 hours.
The sections were washed and incubated with secondary antibody
(lexa Fluor 594-conjugated donkey anti-rabbit IgG) (Invitrogen,
Carlsbad, CA, USA). The sections were then rinsed with PBS and
examined under a fluorescent microscope.
Proliferation and interference experiment
Logarithmic growth phase HeLa cells were digested with trypsin
to single cell suspension and 3000 cells were transferred to each
well of a 96-well plate. CCK-8 (Cell Counting Kit-8) reagent was
added at the time point of 12, 24, 48, 72, 96, and 120 hours after
seeding and incubated at 37uC for half to 4 hours according to the
color change. The data of OD (optical density) value at 450 nm
were read by a microplate reader. Each experiment was
performed 3 times independently.
Wright-Giemsa stain
The staining procedure was based on our previous reports
[9,10]. Cell smears were freshly prepared and dried in open air.
Wright-Giemsa stain solution was placed on the slide to cover all
the cells and incubated for 10 min. The slide was washed and
rinsed with distill water. The slide was viewed under an Olympus
microscope.
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